For pregnant women prone to blood clots, the standard of care has been to provide blood thinners to prevent them and produce better outcomes. A study, authored by Dr. Marc Rodger and published in the July 24 edition of The Lancet demonstrated that for most women, the treatment did not produce the desired effect and indeed exposed them to potential mild complications from the drugs being used.

Dr Marc Rodger is senior scientist at the Ottawa Hospital Research Institute who heads up the Thrombosis Program of The Ottawa Hospital